You are here
BEHAVIORAL PHARMA, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Ethanol Dependence and Kappa Receptor Antagonists
Amount: $871,249.00DESCRIPTION (provided by applicant): In the US, alcoholism is a serious disorder that will affect 14% of the population at some point in their lives. 100,000 US citizens will die of alcoholism each ye ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
New Opioids for Alcoholism
Amount: $161,500.00DESCRIPTION (provided by applicant): Highly potent, orally active, metabolically stable, long-lived opioid agents for the treatment of alcoholism that have decreased side effects such as nausea, addic ...
STTRPhase I2006Department of Health and Human Services National Institutes of Health -
New Opioids for Alcoholism
Amount: $161,500.00DESCRIPTION (provided by applicant): Highly potent, orally active, metabolically stable, long-lived opioid agents for the treatment of alcoholism that have decreased side effects such as nausea, addic ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health